Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Secukinumab Market Growth 2022-2028

  • LP 4974081
  • 127 Pages
  • July 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Secukinumab will have significant change from previous year. According to our (LP Information) latest study, the global Secukinumab market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Secukinumab market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Secukinumab market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Secukinumab market, reaching US$ million by the year 2028. As for the Europe Secukinumab landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Secukinumab players cover Carbosynth, TargetMol Chemicals, Changzhou Chenhong Biotechnology, and DC Chemicals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Secukinumab market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Patent

Generic

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Chemical

Pharmaceutical

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Carbosynth

TargetMol Chemicals

Changzhou Chenhong Biotechnology

DC Chemicals

Huatesheng Biotechnology

Hubei Guangao Biotechnology

Hubei Kele Fine Chemical

Hubei Widely Chemical Technology

Hubei Xingcheng Biotechnology

Hubei Zhongshan Medical Technology

Jiangxi Ruiweier Biotechnology

Nantong Hi-Future Biotechnology

Shanghai Biochempartner

Shanghai Minkai Biotechnology

Shanghai Yifei Biotechnology

Shanghai Yu'ang Chemical

Sichuan Weiqi Biotechnology

Taizhou KEDE Chemical

WeiShi Reagent

Wuhan Dingxintong Pharmaceutical

Wuhan Fortuna Chemical

Wuhan Topule Biopharmaceutical

Wuhan Weisman Bioengineering

Wuhan Yingnuo Pharmaceutical Technology

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Secukinumab Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Secukinumab by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Secukinumab by Country/Region, 2017, 2022 & 2028

2.2 Secukinumab Segment by Type

2.2.1 Patent

2.2.2 Generic

2.3 Secukinumab Sales by Type

2.3.1 Global Secukinumab Sales Market Share by Type (2017-2022)

2.3.2 Global Secukinumab Revenue and Market Share by Type (2017-2022)

2.3.3 Global Secukinumab Sale Price by Type (2017-2022)

2.4 Secukinumab Segment by Application

2.4.1 Chemical

2.4.2 Pharmaceutical

2.5 Secukinumab Sales by Application

2.5.1 Global Secukinumab Sale Market Share by Application (2017-2022)

2.5.2 Global Secukinumab Revenue and Market Share by Application (2017-2022)

2.5.3 Global Secukinumab Sale Price by Application (2017-2022)

3 Global Secukinumab by Company

3.1 Global Secukinumab Breakdown Data by Company

3.1.1 Global Secukinumab Annual Sales by Company (2020-2022)

3.1.2 Global Secukinumab Sales Market Share by Company (2020-2022)

3.2 Global Secukinumab Annual Revenue by Company (2020-2022)

3.2.1 Global Secukinumab Revenue by Company (2020-2022)

3.2.2 Global Secukinumab Revenue Market Share by Company (2020-2022)

3.3 Global Secukinumab Sale Price by Company

3.4 Key Manufacturers Secukinumab Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Secukinumab Product Location Distribution

3.4.2 Players Secukinumab Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Secukinumab by Geographic Region

4.1 World Historic Secukinumab Market Size by Geographic Region (2017-2022)

4.1.1 Global Secukinumab Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Secukinumab Annual Revenue by Geographic Region

4.2 World Historic Secukinumab Market Size by Country/Region (2017-2022)

4.2.1 Global Secukinumab Annual Sales by Country/Region (2017-2022)

4.2.2 Global Secukinumab Annual Revenue by Country/Region

4.3 Americas Secukinumab Sales Growth

4.4 APAC Secukinumab Sales Growth

4.5 Europe Secukinumab Sales Growth

4.6 Middle East & Africa Secukinumab Sales Growth

5 Americas

5.1 Americas Secukinumab Sales by Country

5.1.1 Americas Secukinumab Sales by Country (2017-2022)

5.1.2 Americas Secukinumab Revenue by Country (2017-2022)

5.2 Americas Secukinumab Sales by Type

5.3 Americas Secukinumab Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Secukinumab Sales by Region

6.1.1 APAC Secukinumab Sales by Region (2017-2022)

6.1.2 APAC Secukinumab Revenue by Region (2017-2022)

6.2 APAC Secukinumab Sales by Type

6.3 APAC Secukinumab Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Secukinumab by Country

7.1.1 Europe Secukinumab Sales by Country (2017-2022)

7.1.2 Europe Secukinumab Revenue by Country (2017-2022)

7.2 Europe Secukinumab Sales by Type

7.3 Europe Secukinumab Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Secukinumab by Country

8.1.1 Middle East & Africa Secukinumab Sales by Country (2017-2022)

8.1.2 Middle East & Africa Secukinumab Revenue by Country (2017-2022)

8.2 Middle East & Africa Secukinumab Sales by Type

8.3 Middle East & Africa Secukinumab Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Secukinumab

10.3 Manufacturing Process Analysis of Secukinumab

10.4 Industry Chain Structure of Secukinumab

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Secukinumab Distributors

11.3 Secukinumab Customer

12 World Forecast Review for Secukinumab by Geographic Region

12.1 Global Secukinumab Market Size Forecast by Region

12.1.1 Global Secukinumab Forecast by Region (2023-2028)

12.1.2 Global Secukinumab Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Secukinumab Forecast by Type

12.7 Global Secukinumab Forecast by Application

13 Key Players Analysis

13.1 Carbosynth

13.1.1 Carbosynth Company Information

13.1.2 Carbosynth Secukinumab Product Offered

13.1.3 Carbosynth Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Carbosynth Main Business Overview

13.1.5 Carbosynth Latest Developments

13.2 TargetMol Chemicals

13.2.1 TargetMol Chemicals Company Information

13.2.2 TargetMol Chemicals Secukinumab Product Offered

13.2.3 TargetMol Chemicals Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 TargetMol Chemicals Main Business Overview

13.2.5 TargetMol Chemicals Latest Developments

13.3 Changzhou Chenhong Biotechnology

13.3.1 Changzhou Chenhong Biotechnology Company Information

13.3.2 Changzhou Chenhong Biotechnology Secukinumab Product Offered

13.3.3 Changzhou Chenhong Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Changzhou Chenhong Biotechnology Main Business Overview

13.3.5 Changzhou Chenhong Biotechnology Latest Developments

13.4 DC Chemicals

13.4.1 DC Chemicals Company Information

13.4.2 DC Chemicals Secukinumab Product Offered

13.4.3 DC Chemicals Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 DC Chemicals Main Business Overview

13.4.5 DC Chemicals Latest Developments

13.5 Huatesheng Biotechnology

13.5.1 Huatesheng Biotechnology Company Information

13.5.2 Huatesheng Biotechnology Secukinumab Product Offered

13.5.3 Huatesheng Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Huatesheng Biotechnology Main Business Overview

13.5.5 Huatesheng Biotechnology Latest Developments

13.6 Hubei Guangao Biotechnology

13.6.1 Hubei Guangao Biotechnology Company Information

13.6.2 Hubei Guangao Biotechnology Secukinumab Product Offered

13.6.3 Hubei Guangao Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Hubei Guangao Biotechnology Main Business Overview

13.6.5 Hubei Guangao Biotechnology Latest Developments

13.7 Hubei Kele Fine Chemical

13.7.1 Hubei Kele Fine Chemical Company Information

13.7.2 Hubei Kele Fine Chemical Secukinumab Product Offered

13.7.3 Hubei Kele Fine Chemical Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Hubei Kele Fine Chemical Main Business Overview

13.7.5 Hubei Kele Fine Chemical Latest Developments

13.8 Hubei Widely Chemical Technology

13.8.1 Hubei Widely Chemical Technology Company Information

13.8.2 Hubei Widely Chemical Technology Secukinumab Product Offered

13.8.3 Hubei Widely Chemical Technology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Hubei Widely Chemical Technology Main Business Overview

13.8.5 Hubei Widely Chemical Technology Latest Developments

13.9 Hubei Xingcheng Biotechnology

13.9.1 Hubei Xingcheng Biotechnology Company Information

13.9.2 Hubei Xingcheng Biotechnology Secukinumab Product Offered

13.9.3 Hubei Xingcheng Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Hubei Xingcheng Biotechnology Main Business Overview

13.9.5 Hubei Xingcheng Biotechnology Latest Developments

13.10 Hubei Zhongshan Medical Technology

13.10.1 Hubei Zhongshan Medical Technology Company Information

13.10.2 Hubei Zhongshan Medical Technology Secukinumab Product Offered

13.10.3 Hubei Zhongshan Medical Technology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Hubei Zhongshan Medical Technology Main Business Overview

13.10.5 Hubei Zhongshan Medical Technology Latest Developments

13.11 Jiangxi Ruiweier Biotechnology

13.11.1 Jiangxi Ruiweier Biotechnology Company Information

13.11.2 Jiangxi Ruiweier Biotechnology Secukinumab Product Offered

13.11.3 Jiangxi Ruiweier Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Jiangxi Ruiweier Biotechnology Main Business Overview

13.11.5 Jiangxi Ruiweier Biotechnology Latest Developments

13.12 Nantong Hi-Future Biotechnology

13.12.1 Nantong Hi-Future Biotechnology Company Information

13.12.2 Nantong Hi-Future Biotechnology Secukinumab Product Offered

13.12.3 Nantong Hi-Future Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Nantong Hi-Future Biotechnology Main Business Overview

13.12.5 Nantong Hi-Future Biotechnology Latest Developments

13.13 Shanghai Biochempartner

13.13.1 Shanghai Biochempartner Company Information

13.13.2 Shanghai Biochempartner Secukinumab Product Offered

13.13.3 Shanghai Biochempartner Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Shanghai Biochempartner Main Business Overview

13.13.5 Shanghai Biochempartner Latest Developments

13.14 Shanghai Minkai Biotechnology

13.14.1 Shanghai Minkai Biotechnology Company Information

13.14.2 Shanghai Minkai Biotechnology Secukinumab Product Offered

13.14.3 Shanghai Minkai Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Shanghai Minkai Biotechnology Main Business Overview

13.14.5 Shanghai Minkai Biotechnology Latest Developments

13.15 Shanghai Yifei Biotechnology

13.15.1 Shanghai Yifei Biotechnology Company Information

13.15.2 Shanghai Yifei Biotechnology Secukinumab Product Offered

13.15.3 Shanghai Yifei Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Shanghai Yifei Biotechnology Main Business Overview

13.15.5 Shanghai Yifei Biotechnology Latest Developments

13.16 Shanghai Yu'ang Chemical

13.16.1 Shanghai Yu'ang Chemical Company Information

13.16.2 Shanghai Yu'ang Chemical Secukinumab Product Offered

13.16.3 Shanghai Yu'ang Chemical Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Shanghai Yu'ang Chemical Main Business Overview

13.16.5 Shanghai Yu'ang Chemical Latest Developments

13.17 Sichuan Weiqi Biotechnology

13.17.1 Sichuan Weiqi Biotechnology Company Information

13.17.2 Sichuan Weiqi Biotechnology Secukinumab Product Offered

13.17.3 Sichuan Weiqi Biotechnology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Sichuan Weiqi Biotechnology Main Business Overview

13.17.5 Sichuan Weiqi Biotechnology Latest Developments

13.18 Taizhou KEDE Chemical

13.18.1 Taizhou KEDE Chemical Company Information

13.18.2 Taizhou KEDE Chemical Secukinumab Product Offered

13.18.3 Taizhou KEDE Chemical Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Taizhou KEDE Chemical Main Business Overview

13.18.5 Taizhou KEDE Chemical Latest Developments

13.19 WeiShi Reagent

13.19.1 WeiShi Reagent Company Information

13.19.2 WeiShi Reagent Secukinumab Product Offered

13.19.3 WeiShi Reagent Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 WeiShi Reagent Main Business Overview

13.19.5 WeiShi Reagent Latest Developments

13.20 Wuhan Dingxintong Pharmaceutical

13.20.1 Wuhan Dingxintong Pharmaceutical Company Information

13.20.2 Wuhan Dingxintong Pharmaceutical Secukinumab Product Offered

13.20.3 Wuhan Dingxintong Pharmaceutical Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Wuhan Dingxintong Pharmaceutical Main Business Overview

13.20.5 Wuhan Dingxintong Pharmaceutical Latest Developments

13.21 Wuhan Fortuna Chemical

13.21.1 Wuhan Fortuna Chemical Company Information

13.21.2 Wuhan Fortuna Chemical Secukinumab Product Offered

13.21.3 Wuhan Fortuna Chemical Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Wuhan Fortuna Chemical Main Business Overview

13.21.5 Wuhan Fortuna Chemical Latest Developments

13.22 Wuhan Topule Biopharmaceutical

13.22.1 Wuhan Topule Biopharmaceutical Company Information

13.22.2 Wuhan Topule Biopharmaceutical Secukinumab Product Offered

13.22.3 Wuhan Topule Biopharmaceutical Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Wuhan Topule Biopharmaceutical Main Business Overview

13.22.5 Wuhan Topule Biopharmaceutical Latest Developments

13.23 Wuhan Weisman Bioengineering

13.23.1 Wuhan Weisman Bioengineering Company Information

13.23.2 Wuhan Weisman Bioengineering Secukinumab Product Offered

13.23.3 Wuhan Weisman Bioengineering Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Wuhan Weisman Bioengineering Main Business Overview

13.23.5 Wuhan Weisman Bioengineering Latest Developments

13.24 Wuhan Yingnuo Pharmaceutical Technology

13.24.1 Wuhan Yingnuo Pharmaceutical Technology Company Information

13.24.2 Wuhan Yingnuo Pharmaceutical Technology Secukinumab Product Offered

13.24.3 Wuhan Yingnuo Pharmaceutical Technology Secukinumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Wuhan Yingnuo Pharmaceutical Technology Main Business Overview

13.24.5 Wuhan Yingnuo Pharmaceutical Technology Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Secukinumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Secukinumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Patent

Table 4. Major Players of Generic

Table 5. Global Secukinumab Sales by Type (2017-2022) & (Kg)

Table 6. Global Secukinumab Sales Market Share by Type (2017-2022)

Table 7. Global Secukinumab Revenue by Type (2017-2022) & ($ million)

Table 8. Global Secukinumab Revenue Market Share by Type (2017-2022)

Table 9. Global Secukinumab Sale Price by Type (2017-2022) & (US$/Kg)

Table 10. Global Secukinumab Sales by Application (2017-2022) & (Kg)

Table 11. Global Secukinumab Sales Market Share by Application (2017-2022)

Table 12. Global Secukinumab Revenue by Application (2017-2022)

Table 13. Global Secukinumab Revenue Market Share by Application (2017-2022)

Table 14. Global Secukinumab Sale Price by Application (2017-2022) & (US$/Kg)

Table 15. Global Secukinumab Sales by Company (2020-2022) & (Kg)

Table 16. Global Secukinumab Sales Market Share by Company (2020-2022)

Table 17. Global Secukinumab Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Secukinumab Revenue Market Share by Company (2020-2022)

Table 19. Global Secukinumab Sale Price by Company (2020-2022) & (US$/Kg)

Table 20. Key Manufacturers Secukinumab Producing Area Distribution and Sales Area

Table 21. Players Secukinumab Products Offered

Table 22. Secukinumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Secukinumab Sales by Geographic Region (2017-2022) & (Kg)

Table 26. Global Secukinumab Sales Market Share Geographic Region (2017-2022)

Table 27. Global Secukinumab Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Secukinumab Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Secukinumab Sales by Country/Region (2017-2022) & (Kg)

Table 30. Global Secukinumab Sales Market Share by Country/Region (2017-2022)

Table 31. Global Secukinumab Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Secukinumab Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Secukinumab Sales by Country (2017-2022) & (Kg)

Table 34. Americas Secukinumab Sales Market Share by Country (2017-2022)

Table 35. Americas Secukinumab Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Secukinumab Revenue Market Share by Country (2017-2022)

Table 37. Americas Secukinumab Sales by Type (2017-2022) & (Kg)

Table 38. Americas Secukinumab Sales Market Share by Type (2017-2022)

Table 39. Americas Secukinumab Sales by Application (2017-2022) & (Kg)

Table 40. Americas Secukinumab Sales Market Share by Application (2017-2022)

Table 41. APAC Secukinumab Sales by Region (2017-2022) & (Kg)

Table 42. APAC Secukinumab Sales Market Share by Region (2017-2022)

Table 43. APAC Secukinumab Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Secukinumab Revenue Market Share by Region (2017-2022)

Table 45. APAC Secukinumab Sales by Type (2017-2022) & (Kg)

Table 46. APAC Secukinumab Sales Market Share by Type (2017-2022)

Table 47. APAC Secukinumab Sales by Application (2017-2022) & (Kg)

Table 48. APAC Secukinumab Sales Market Share by Application (2017-2022)

Table 49. Europe Secukinumab Sales by Country (2017-2022) & (Kg)

Table 50. Europe Secukinumab Sales Market Share by Country (2017-2022)

Table 51. Europe Secukinumab Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Secukinumab Revenue Market Share by Country (2017-2022)

Table 53. Europe Secukinumab Sales by Type (2017-2022) & (Kg)

Table 54. Europe Secukinumab Sales Market Share by Type (2017-2022)

Table 55. Europe Secukinumab Sales by Application (2017-2022) & (Kg)

Table 56. Europe Secukinumab Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Secukinumab Sales by Country (2017-2022) & (Kg)

Table 58. Middle East & Africa Secukinumab Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Secukinumab Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Secukinumab Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Secukinumab Sales by Type (2017-2022) & (Kg)

Table 62. Middle East & Africa Secukinumab Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Secukinumab Sales by Application (2017-2022) & (Kg)

Table 64. Middle East & Africa Secukinumab Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Secukinumab

Table 66. Key Market Challenges & Risks of Secukinumab

Table 67. Key Industry Trends of Secukinumab

Table 68. Secukinumab Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Secukinumab Distributors List

Table 71. Secukinumab Customer List

Table 72. Global Secukinumab Sales Forecast by Region (2023-2028) & (Kg)

Table 73. Global Secukinumab Sales Market Forecast by Region

Table 74. Global Secukinumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Secukinumab Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Secukinumab Sales Forecast by Country (2023-2028) & (Kg)

Table 77. Americas Secukinumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Secukinumab Sales Forecast by Region (2023-2028) & (Kg)

Table 79. APAC Secukinumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Secukinumab Sales Forecast by Country (2023-2028) & (Kg)

Table 81. Europe Secukinumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Secukinumab Sales Forecast by Country (2023-2028) & (Kg)

Table 83. Middle East & Africa Secukinumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Secukinumab Sales Forecast by Type (2023-2028) & (Kg)

Table 85. Global Secukinumab Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Secukinumab Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Secukinumab Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Secukinumab Sales Forecast by Application (2023-2028) & (Kg)

Table 89. Global Secukinumab Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Secukinumab Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Secukinumab Revenue Market Share Forecast by Application (2023-2028)

Table 92. Carbosynth Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 93. Carbosynth Secukinumab Product Offered

Table 94. Carbosynth Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 95. Carbosynth Main Business

Table 96. Carbosynth Latest Developments

Table 97. TargetMol Chemicals Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 98. TargetMol Chemicals Secukinumab Product Offered

Table 99. TargetMol Chemicals Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 100. TargetMol Chemicals Main Business

Table 101. TargetMol Chemicals Latest Developments

Table 102. Changzhou Chenhong Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 103. Changzhou Chenhong Biotechnology Secukinumab Product Offered

Table 104. Changzhou Chenhong Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 105. Changzhou Chenhong Biotechnology Main Business

Table 106. Changzhou Chenhong Biotechnology Latest Developments

Table 107. DC Chemicals Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 108. DC Chemicals Secukinumab Product Offered

Table 109. DC Chemicals Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 110. DC Chemicals Main Business

Table 111. DC Chemicals Latest Developments

Table 112. Huatesheng Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 113. Huatesheng Biotechnology Secukinumab Product Offered

Table 114. Huatesheng Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 115. Huatesheng Biotechnology Main Business

Table 116. Huatesheng Biotechnology Latest Developments

Table 117. Hubei Guangao Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 118. Hubei Guangao Biotechnology Secukinumab Product Offered

Table 119. Hubei Guangao Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 120. Hubei Guangao Biotechnology Main Business

Table 121. Hubei Guangao Biotechnology Latest Developments

Table 122. Hubei Kele Fine Chemical Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 123. Hubei Kele Fine Chemical Secukinumab Product Offered

Table 124. Hubei Kele Fine Chemical Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 125. Hubei Kele Fine Chemical Main Business

Table 126. Hubei Kele Fine Chemical Latest Developments

Table 127. Hubei Widely Chemical Technology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 128. Hubei Widely Chemical Technology Secukinumab Product Offered

Table 129. Hubei Widely Chemical Technology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 130. Hubei Widely Chemical Technology Main Business

Table 131. Hubei Widely Chemical Technology Latest Developments

Table 132. Hubei Xingcheng Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 133. Hubei Xingcheng Biotechnology Secukinumab Product Offered

Table 134. Hubei Xingcheng Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 135. Hubei Xingcheng Biotechnology Main Business

Table 136. Hubei Xingcheng Biotechnology Latest Developments

Table 137. Hubei Zhongshan Medical Technology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 138. Hubei Zhongshan Medical Technology Secukinumab Product Offered

Table 139. Hubei Zhongshan Medical Technology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 140. Hubei Zhongshan Medical Technology Main Business

Table 141. Hubei Zhongshan Medical Technology Latest Developments

Table 142. Jiangxi Ruiweier Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 143. Jiangxi Ruiweier Biotechnology Secukinumab Product Offered

Table 144. Jiangxi Ruiweier Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 145. Jiangxi Ruiweier Biotechnology Main Business

Table 146. Jiangxi Ruiweier Biotechnology Latest Developments

Table 147. Nantong Hi-Future Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 148. Nantong Hi-Future Biotechnology Secukinumab Product Offered

Table 149. Nantong Hi-Future Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 150. Nantong Hi-Future Biotechnology Main Business

Table 151. Nantong Hi-Future Biotechnology Latest Developments

Table 152. Shanghai Biochempartner Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 153. Shanghai Biochempartner Secukinumab Product Offered

Table 154. Shanghai Biochempartner Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 155. Shanghai Biochempartner Main Business

Table 156. Shanghai Biochempartner Latest Developments

Table 157. Shanghai Minkai Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 158. Shanghai Minkai Biotechnology Secukinumab Product Offered

Table 159. Shanghai Minkai Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 160. Shanghai Minkai Biotechnology Main Business

Table 161. Shanghai Minkai Biotechnology Latest Developments

Table 162. Shanghai Yifei Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 163. Shanghai Yifei Biotechnology Secukinumab Product Offered

Table 164. Shanghai Yifei Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 165. Shanghai Yifei Biotechnology Main Business

Table 166. Shanghai Yifei Biotechnology Latest Developments

Table 167. Shanghai Yu'ang Chemical Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 168. Shanghai Yu'ang Chemical Secukinumab Product Offered

Table 169. Shanghai Yu'ang Chemical Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 170. Shanghai Yu'ang Chemical Main Business

Table 171. Shanghai Yu'ang Chemical Latest Developments

Table 172. Sichuan Weiqi Biotechnology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 173. Sichuan Weiqi Biotechnology Secukinumab Product Offered

Table 174. Sichuan Weiqi Biotechnology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 175. Sichuan Weiqi Biotechnology Main Business

Table 176. Sichuan Weiqi Biotechnology Latest Developments

Table 177. Taizhou KEDE Chemical Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 178. Taizhou KEDE Chemical Secukinumab Product Offered

Table 179. Taizhou KEDE Chemical Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 180. Taizhou KEDE Chemical Main Business

Table 181. Taizhou KEDE Chemical Latest Developments

Table 182. WeiShi Reagent Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 183. WeiShi Reagent Secukinumab Product Offered

Table 184. WeiShi Reagent Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 185. WeiShi Reagent Main Business

Table 186. WeiShi Reagent Latest Developments

Table 187. Wuhan Dingxintong Pharmaceutical Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 188. Wuhan Dingxintong Pharmaceutical Secukinumab Product Offered

Table 189. Wuhan Dingxintong Pharmaceutical Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 190. Wuhan Dingxintong Pharmaceutical Main Business

Table 191. Wuhan Dingxintong Pharmaceutical Latest Developments

Table 192. Wuhan Fortuna Chemical Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 193. Wuhan Fortuna Chemical Secukinumab Product Offered

Table 194. Wuhan Fortuna Chemical Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 195. Wuhan Fortuna Chemical Main Business

Table 196. Wuhan Fortuna Chemical Latest Developments

Table 197. Wuhan Topule Biopharmaceutical Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 198. Wuhan Topule Biopharmaceutical Secukinumab Product Offered

Table 199. Wuhan Topule Biopharmaceutical Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 200. Wuhan Topule Biopharmaceutical Main Business

Table 201. Wuhan Topule Biopharmaceutical Latest Developments

Table 202. Wuhan Weisman Bioengineering Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 203. Wuhan Weisman Bioengineering Secukinumab Product Offered

Table 204. Wuhan Weisman Bioengineering Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 205. Wuhan Weisman Bioengineering Main Business

Table 206. Wuhan Weisman Bioengineering Latest Developments

Table 207. Wuhan Yingnuo Pharmaceutical Technology Basic Information, Secukinumab Manufacturing Base, Sales Area and Its Competitors

Table 208. Wuhan Yingnuo Pharmaceutical Technology Secukinumab Product Offered

Table 209. Wuhan Yingnuo Pharmaceutical Technology Secukinumab Sales (Kg), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)

Table 210. Wuhan Yingnuo Pharmaceutical Technology Main Business

Table 211. Wuhan Yingnuo Pharmaceutical Technology Latest Developments

List of Figures

Figure 1. Picture of Secukinumab

Figure 2. Secukinumab Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Secukinumab Sales Growth Rate 2017-2028 (Kg)

Figure 7. Global Secukinumab Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Secukinumab Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Patent

Figure 10. Product Picture of Generic

Figure 11. Global Secukinumab Sales Market Share by Type in 2021

Figure 12. Global Secukinumab Revenue Market Share by Type (2017-2022)

Figure 13. Secukinumab Consumed in Chemical

Figure 14. Global Secukinumab Market: Chemical (2017-2022) & (Kg)

Figure 15. Secukinumab Consumed in Pharmaceutical

Figure 16. Global Secukinumab Market: Pharmaceutical (2017-2022) & (Kg)

Figure 17. Global Secukinumab Sales Market Share by Application (2017-2022)

Figure 18. Global Secukinumab Revenue Market Share by Application in 2021

Figure 19. Secukinumab Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Secukinumab Revenue Market Share by Company in 2021

Figure 21. Global Secukinumab Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Secukinumab Revenue Market Share by Geographic Region in 2021

Figure 23. Global Secukinumab Sales Market Share by Region (2017-2022)

Figure 24. Global Secukinumab Revenue Market Share by Country/Region in 2021

Figure 25. Americas Secukinumab Sales 2017-2022 (Kg)

Figure 26. Americas Secukinumab Revenue 2017-2022 ($ Millions)

Figure 27. APAC Secukinumab Sales 2017-2022 (Kg)

Figure 28. APAC Secukinumab Revenue 2017-2022 ($ Millions)

Figure 29. Europe Secukinumab Sales 2017-2022 (Kg)

Figure 30. Europe Secukinumab Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Secukinumab Sales 2017-2022 (Kg)

Figure 32. Middle East & Africa Secukinumab Revenue 2017-2022 ($ Millions)

Figure 33. Americas Secukinumab Sales Market Share by Country in 2021

Figure 34. Americas Secukinumab Revenue Market Share by Country in 2021

Figure 35. United States Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Secukinumab Sales Market Share by Region in 2021

Figure 40. APAC Secukinumab Revenue Market Share by Regions in 2021

Figure 41. China Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Secukinumab Sales Market Share by Country in 2021

Figure 48. Europe Secukinumab Revenue Market Share by Country in 2021

Figure 49. Germany Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Secukinumab Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Secukinumab Revenue Market Share by Country in 2021

Figure 56. Egypt Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Secukinumab Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Secukinumab in 2021

Figure 62. Manufacturing Process Analysis of Secukinumab

Figure 63. Industry Chain Structure of Secukinumab

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370